English | Español
Patient Daily | Dec 21, 2025

Immunome plans FDA submission after positive phase III data for desmoid tumor drug
Patient Daily | Dec 21, 2025

FDA set to decide on key drugs from GSK, Aldeyra, Rhythm before year-end
Patient Daily | Dec 21, 2025

Major clinical trial failures mark challenging year for biopharma companies
Patient Daily | Dec 21, 2025

Sanofi reports phase III failure and new FDA delay for MS drug
Patient Daily | Dec 21, 2025

Baylor College expert advises vigilance against holiday season scams targeting seniors
Patient Daily | Dec 21, 2025

American College of Allergy urges practical resolutions for allergy and asthma management in 2026
Patient Daily | Dec 21, 2025

Johns Hopkins study finds sex differences in visual system recovery after brain injury
Patient Daily | Dec 21, 2025

Canada’s reduced Global Fund pledge raises concerns over domestic and global disease control

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
L. R. Alvarez | Jul 30, 2026

TPA's Ross Marchand on 340B: 'Taxpayers are picking up the tab for the program's many failures and mission creep'
+ Pharmaceuticals
Patient Daily | Jul 30, 2026

Jefferies analysts say Daiichi Sankyo’s pipeline lags as cash flow nears peak
+ Pharmaceuticals
Patient Daily | Jul 29, 2026

AI-enabled tool linked to fewer deaths among high-risk hospitalized patients, study finds